Delivery Order SPE2DB24D2018-SPE2DB25FWVY7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,722.19 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,979.42 on December 10, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injections. This firm fixed-price, competitively awarded contract—with no set-aside designation—is scheduled for completion by December 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $13,618.11 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on September 12, 2025, with a completion date of September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,159.40 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen injections with an ultimate completion date of December 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a distribution hub for federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injections valued at $6,422.82, with completion expected by September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $5,441.80 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,081.35 for Mounjaro 10 mg/0.5 ml pen injectors on July 23, 2025, with ultimate completion by July 24, 2025. This firm fixed-price, competitively awarded contract involves pharmaceutical delivery to support federal medical procurement needs. The contract is issued without set-aside designation, reflecting open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injections, with a contract ceiling value of $2,720.90 and a completion date of June 26, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction under AmerisourceBergen's existing federal contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which is also the company's...
- The Defense Logistics Agency awarded a delivery order valued at $17,864.31 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injections on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The product will be delivered to...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWVY7Delivery Order
The Defense Logistics Agency awarded a $4,550.91 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injections on July 31, 2025, with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract demonstrates AmerisourceBergen Drug Corp's established capability to fulfill federal medical supply requirements through open competition and its integral role in supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/31/25 |